Admission prevention in COPD: Non-pharmacological management

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Suh, Eui Sik ^a,b   Mandal, Swapna ^a,b   Hart, Nicholas ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MORTALITY; NONINVASIVE VENTILATION; OXYGEN THERAPY; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; SMOKING CESSATION; TREATMENT FAILURE; TREATMENT OUTCOME;

AUSTRALASIA; EUROPE; HUMANS; NORTH AMERICA; PATIENT ADMISSION; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84888044630     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-247     Document Type: Review

References (108)

1. White P. Prevalence of COPD in primary care: no room for complacency. Fam Pract 2009, 26:1-2.
2. Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. NCHS Data Brief 2011, 63:1-8.
3. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007, 176:753-760. 10.1164/rccm.200612-1749OC, 17575095.
4. Lin H-H, Murray M, Cohen T, Colijn C, Ezzati M. Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. The Lancet 2008, 372:1473-1483.
5. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002, 51:1-16.
6. National Heart, Lung and Blood Institute. Morbidity and Mortality 2009 Chartbook of Cardiovascular, Lung and Blood Diseases 2009, Bethesda (MD): National Institutes of Health, National Heart, Lung and Blood Institute. Morbidity and Mortality.
7. National Collaborating Centre for Chronic Conditions Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004, 59:1-232. 1766028, 15041752, National Collaborating Centre for Chronic Conditions.
8. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010, 182:598-604. 10.1164/rccm.200912-1843CC, 20522794.
9. Wedzicha JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med 2013, 11:181. 10.1186/1741-7015-11-181, 3750926, 23945277.
10. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31:416-469. 10.1183/09031936.00099306, 18238951.
11. Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, Maccallum PK, Wedzicha JA. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005, 128:1995-2004. 10.1378/chest.128.4.1995, 16236847.
12. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852. 10.1136/thorax.57.10.847, 1746193, 12324669.
13. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PMA. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease. Am J Res Crit Care Med 2008, 178:332-338.
14. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PMA, Celli B, Coxson HO, Crim C, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Eng J Med 2011, 365:1184-1192.
15. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422. 10.1164/ajrccm.157.5.9709032, 9603117.
16. Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis 2012, 7:653-661. 3459660, 23055714.
17. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, España PP, Pérez-Izquierdo J, Aguirre U, Aizpiri S, Capelastegui A. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med 2009, 103:1201-1208. 10.1016/j.rmed.2009.02.002, 19272762.
18. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007, 131:696-704. 10.1378/chest.06-1610, 17356082.
19. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60:925-931. 10.1136/thx.2005.040527, 1747235, 16055622.
20. Almagro P, Calbo E, Ochoa De Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau U. Mortality after hospitalization for COPD. Chest 2002, 121:1441-1448. 10.1378/chest.121.5.1441, 12006426.
21. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003, 124:459-467. 10.1378/chest.124.2.459, 12907529.
22. Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax 2012, 67:117-121. 10.1136/thoraxjnl-2011-200332, 21896712.
23. Connors A, Dawson N, Thomas C, Harrell F, Desbiens N, Fulkerson W, Kussin P, Bellamy P, Goldman L, Knaus W. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 1996, 154:959-967. 10.1164/ajrccm.154.4.8887592, 8887592.
24. Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thoracic Soc 2013, 10:81-89.
25. O'Donnell DE, Parker CM. COPD exacerbations. 3: pathophysiology. Thorax 2006, 61:354-361. 10.1136/thx.2005.041830, 2104611, 16565268.
26. Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013, 187:596-601. 10.1164/rccm.201211-2044OC, 23328526.
27. Royal College of Physicians, British Thoracic Society, British Lung Foundation Report of the national chronic obstructive pulmonary disease audit 2008: clinical audit of COPD exacerbations admitted to acute NHS trusts across the UK. 2008, Royal College of Physicians, Royal College of Physicians, British Thoracic Society, British Lung Foundation.
28. Anstey K, Lowe D, Roberts CM, Hosker H. Report of the 2003 National COPD Audit 2004, London: Royal College of Physicians/British Thoracic Society.
29. Westert GP, Lagoe RJ, Keskimäki I, Leyland A, Murphy M. An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy 2002, 61:269-278. 10.1016/S0168-8510(01)00236-6, 12098520.
30. Reineck LA, Kahn JM. Quality measurement in the affordable care Act. A reaffirmed commitment to value in health care. Am J Res Crit Care Med 2013, 187:1038-1039.
31. Nici L, ZuWallack R, Wouters E, Donner CF. On pulmonary rehabilitation and the flight of the bumblebee: the ATS/ERS statement on pulmonary rehabilitation. Eur Respir J 2006, 28:461-462. 10.1183/09031936.06.00075106, 16946088.
32. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185. 10.1183/09031936.00128008, 19407051.
33. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996, 153:288-293. 10.1164/ajrccm.153.1.8542131, 8542131.
34. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005, 128:2025-2034. 10.1378/chest.128.4.2025, 16236851.
35. Hawkins P, Johnson LC, Nikoletou D, Hamnegard CH, Sherwood R, Polkey MI, Moxham J. Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax 2002, 57:853-859. 10.1136/thorax.57.10.853, 1746205, 12324670.
36. Gayan-Ramirez G, Decramer M. Mechanisms of striated muscle dysfunction during acute exacerbations of COPD. J App Physiol 2013, 114:1291-1299.
37. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer M. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003, 58:752-756. 10.1136/thorax.58.9.752, 1746817, 12947130.
38. Crul T, Testelmans D, Spruit MA, Troosters T, Gosselink R, Geeraerts I, Decramer M, Gayan-Ramirez G. Gene expression profiling in vastus lateralis muscle during an acute exacerbation of COPD. Cell Physiol Biochem 2010, 25:491-500. 10.1159/000303054, 20332630.
39. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008, 3:637-658. 2650609, 19281080.
40. Vianna LG, Koulouris N, Lanigan C, Moxham J. Effect of acute hypercapnia on limb muscle contractility in humans. J Appl Physiol 1990, 69:1486-1493.
41. Juan G, Calverley P, Talamo C, Schnader J, Roussos C. Effect of carbon dioxide on diaphragmatic function in human beings. N Engl J Med 1984, 310:874-879. 10.1056/NEJM198404053101402, 6422298.
42. Vermeeren M, Schols A, Wouters E. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Euro Respir J 1997, 10:2264-2269.
43. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006, 173:1390-1413. 10.1164/rccm.200508-1211ST, 16760357.
44. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006, 173:79-83.
45. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA. Anxiety and depression in copd: current understanding, unanswered questions, and research needs. CHEST Journal 2008, 134:43S-56S.
46. Bhandari NJ, Jain T, Marolda C, ZuWallack RL. Comprehensive pulmonary rehabilitation results in clinically meaningful improvements in anxiety and depression in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2013, 33:123-127. 10.1097/HCR.0b013e31828254d4, 23399845.
47. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, 4. CD003793.
48. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011, 10. CD005305.
49. Kon SS, Canavan JL, Man WD. Pulmonary rehabilitation and acute exacerbations of COPD. Expert Rev Respir Med 2012, 6:523-531. quiz 531, 10.1586/ers.12.47, 23134247.
50. Seymour JM, Moore L, Jolley CJ, Ward K, Creasey J, Steier JS, Yung B, Man WD, Hart N, Polkey MI, et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax 2010, 65:423-428. 10.1136/thx.2009.124164, 20435864.
51. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006, 129:536-544. 10.1378/chest.129.3.536, 16537849.
52. Eaton T, Young P, Fergusson W, Moodie L, Zeng I, O'Kane F, Good N, Rhodes L, Poole P, Kolbe J. Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study. Respirology 2009, 14:230-238. 10.1111/j.1440-1843.2008.01418.x, 19272084.
53. Ko FW, Dai DL, Ngai J, Tung A, Ng S, Lai K, Fong R, Lau H, Tam W, Hui DS. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD. Respirology 2011, 16:617-624. 10.1111/j.1440-1843.2010.01921.x, 21199163.
54. Puhan MA, Spaar A, Frey M, Turk A, Brandli O, Ritscher D, Achermann E, Kaelin R, Karrer W. Early versus late pulmonary rehabilitation in chronic obstructive pulmonary disease patients with acute exacerbations: a randomized trial. Respiration 2012, 83:499-506. 10.1159/000329884, 21846962.
55. Maddocks M, Gao W, Higginson IJ, Wilcock A. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev 2013, 1. CD009419.
56. Dyer F, Flude L, Bazari F, Jolley C, Englebretsen C, Lai D, Polkey MI, Hopkinson NS. Non-invasive ventilation (NIV) as an aid to rehabilitation in acute respiratory disease. BMC Pulm Med 2011, 11:58. 10.1186/1471-2466-11-58, 3260154, 22177338.
57. Raskin J, Spiegler P, McCusker C, ZuWallack R, Bernstein M, Busby J, DiLauro P, Griffiths K, Haggerty M, Hovey L, et al. The effect of pulmonary rehabilitation on healthcare utilization in chronic obstructive pulmonary disease: the northeast pulmonary rehabilitation consortium. J Cardiopulm Rehabil 2006, 26:231-236. 10.1097/00008483-200607000-00006, 16926687.
58. Cecins N, Geelhoed E, Jenkins SC. Reduction in hospitalisation following pulmonary rehabilitation in patients with COPD. Aust Health Rev 2008, 32:415-422. 10.1071/AH080415, 18666869.
59. Hui KP, Hewitt AB. A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest 2003, 124:94-97. 10.1378/chest.124.1.94, 12853508.
60. Chakravorty I, Fasakin C, Paine T, Narasimhaiah D, Austin G. Outpatient-based pulmonary rehabilitation for COPD: a cost of illness study. ISRN Pulmonol 2011, 2011:6.
61. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000, 355:362-368. 10.1016/S0140-6736(99)07042-7, 10665556.
62. Guell R, Casan P, Belda J, Sangenis M, Morante F, Guyatt GH, Sanchis J. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000, 117:976-983. 10.1378/chest.117.4.976, 10767227.
63. Engstrom CP, Persson LO, Larsson S, Sullivan M. Long-term effects of a pulmonary rehabilitation programme in outpatients with chronic obstructive pulmonary disease: a randomized controlled study. Scand J Rehabil Med 1999, 31:207-213. 10.1080/003655099444371, 10599897.
64. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995, 122:823-832. 10.7326/0003-4819-122-11-199506010-00003, 7741366.
65. Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000, 355:1931-1935. 10.1016/S0140-6736(00)02323-0, 10859037.
66. British Thoracic Society, Royal College of Physicians (London), Intensive Care Society The Use of Non-Invasive Ventilation in the management of patients with chronic obstructive pulmonary disease admitted to hospital with acute type II respiratory failure (with particular reference to Bilevel positive pressure ventilation). 2008, London: British Thoracic Society, Royal College of Physicians (London), Intensive Care Society, British Thoracic Society, Royal College of Physicians (London), Intensive Care Society.
67. Kallet RH, Diaz JV. The physiologic effects of noninvasive ventilation. Respir Care 2009, 54:102-115.
68. Nickol AH, Hart N, Hopkinson NS, Hamnegard CH, Moxham J, Simonds A, Polkey MI. Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV. Int J Chron Obstruct Pulmon Dis 2008, 3:453-462. 2629992, 18990974.
69. Tuggey JM, Plant PK, Elliott MW. Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis. Thorax 2003, 58:867-871. 10.1136/thorax.58.10.867, 1746494, 14514940.
70. Casanova C, Celli BR, Tost L, Soriano E, Abreu J, Velasco V, Santolaria F. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 2000, 118:1582-1590. 10.1378/chest.118.6.1582, 11115443.
71. Clini E, Sturani C, Rossi A, Viaggi S, Corrado A, Donner CF, Ambrosino N. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002, 20:529-538. 10.1183/09031936.02.02162001, 12358325.
72. McEvoy RD, Pierce RJ, Hillman D, Esterman A, Ellis EE, Catcheside PG, O'Donoghue FJ, Barnes DJ, Grunstein RR. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 2009, 64:561-566. 10.1136/thx.2008.108274, 19213769.
73. Chu CM, Chan VL, Lin AW, Wong IW, Leung WS, Lai CK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004, 59:1020-1025. 10.1136/thx.2004.024307, 1746916, 15563699.
74. Cheung AP, Chan VL, Liong JT, Lam JY, Leung WS, Lin A, Chu CM. A pilot trial of non-invasive home ventilation after acidotic respiratory failure in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 2010, 14:642-649.
75. Funk GC, Breyer MK, Burghuber OC, Kink E, Kirchheiner K, Kohansal R, Schmidt I, Hartl S. Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure. Respir Med 2011, 105:427-434. 10.1016/j.rmed.2010.09.005, 21111590.
76. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, Escarabill J, Farre R, Fauroux B, Robert D, Schoenhofer B, Simonds AK, Wedzicha JA. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 2005, 25:1025-1031. 10.1183/09031936.05.00066704, 15929957.
77. NAMDRC Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation-a consensus conference report. Chest 1999, 116:521-534. NAMDRC.
78. Costello R, Deegan P, Fitzpatrick M, McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med 1997, 102:239-244. 10.1016/S0002-9343(97)00017-X, 9217591.
79. McNally E, Fitzpatrick M, Bourke S, Costello R, McNicholas WT. Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J 1993, 6:1353-1356.
80. Murphy P, Gibson GJ, Polkey MI, Hart N. HOT HMV UK: prevalence of persistent significant hypercapnia following acute exacerbation of COPD (AECOPD) requiring non-invasive ventilation (NIV) [Abstract]. Thorax 2010, 65:A33.
81. http://www.clinicaltrials.gov NCT00990132.
82. http://www.trialregister.nl NTR1100.
83. Miro AM, Shivaram U, Hertig I. COntinuous positive airway pressure in copd patients in acute hypercapnic respiratory failure. CHEST Journal 1993, 103:266-268.
84. Goldberg P, Reissmann H, Maltais F, Ranieri M, Gottfried SB. Efficacy of noninvasive CPAP in COPD with acute respiratory failure. Eur Respir J 1995, 8:1894-1900. 10.1183/09031936.95.08111894, 8620959.
85. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung health study research G: hospitalizations and mortality in the lung health study. Am J Respir Crit Care Med 2002, 166:333-339. 10.1164/rccm.2110093, 12153966.
86. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:158-164. 10.1164/ajrccm.159.1.9803117, 9872834.
87. Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Felez MA, Sunyer J, Anto JM. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2001, 164:1002-1007. 10.1164/ajrccm.164.6.2006012, 11587986.
88. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 2002, 57:967-972. 10.1136/thorax.57.11.967, 1746230, 12403880.
89. Au DH, Bryson CL, Chien JW, Sun H, Udris EM, Evans LE, Bradley KA. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med 2009, 24:457-463. 10.1007/s11606-009-0907-y, 2659150, 19194768.
90. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981, 1:681-686.
91. Is 12-hour oxygen as effective as 24-hour oxygen in advanced chronic obstructive pulmonary disease with hypoxemia? (The Nocturnal Oxygen Therapy Trial-NOTT). Chest 1980, 78:419-420.
92. Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?. Eur Respir J 2002, 20:38-42. 10.1183/09031936.02.00284202, 12166578.
93. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Vessey RS, Wedzicha JA. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174:867-874. 10.1164/rccm.200604-506OC, 16799074.
94. Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pulmonary disease. Translational Res 2012, 159:228-237.
95. Stevenson NJ, Walker PP, Costello RW, Calverley PMA. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 172:1510-1516. 10.1164/rccm.200504-595OC, 16166620.
96. Murphy PB, Kumar A, Reilly C, Jolley C, Walterspacher S, Fedele F, Hopkinson NS, Man WD, Polkey MI, Moxham J, et al. Neural respiratory drive as a physiological biomarker to monitor change during acute exacerbations of COPD. Thorax 2011, 66:602-608. 10.1136/thx.2010.151332, 21597112.
97. Cotton MM, Bucknall CE, Dagg KD, Johnson MK, MacGregor G, Stewart C, Stevenson RD. Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Thorax 2000, 55:902-906. 10.1136/thorax.55.11.902, 1745631, 11050257.
98. Skwarska E, Cohen G, Skwarski KM, Lamb C, Bushell D, Parker S, MacNee W. Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax 2000, 55:907-912. 10.1136/thorax.55.11.907, 1745644, 11050258.
99. Jeppesen E, Brurberg KG, Vist GE, Wedzicha JA, Wright JJ, Greenstone M, Walters JA. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012, 5. CD003573.
100. McLean S, Nurmatov U, Liu JL, Pagliari C, Car J, Sheikh A. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011, 7. CD007718.
101. McKinstry B, Pinnock H, Sheikh A. Telemedicine for management of patients with COPD?. Lancet 2009, 374:672-673. 10.1016/S0140-6736(09)61542-7, 19716948.
102. Bolton CE, Waters CS, Peirce S, Elwyn G. Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Prac 2011, 17:1216-1222.
103. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, Scott RE. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare 2010, 16:120-127. 10.1258/jtt.2009.090812, 20197355.
104. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, et al. Effect of telehealth on use of secondary care and mortality: findings from the whole system demonstrator cluster randomised trial. BMJ 2012, 344:e3874. 10.1136/bmj.e3874, 3381047, 22723612.
105. Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, Bardsley M, Steventon A, Knapp M, Henderson C, et al. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator Telehealth Questionnaire Study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ 2013, 346:f653. 10.1136/bmj.f653, 3582704, 23444424.
106. Henderson C, Knapp M, Fernandez JL, Beecham J, Hirani SP, Cartwright M, Rixon L, Beynon M, Rogers A, Bower P, et al. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator Telehealth Questionnaire Study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ 2013, 346:f1035. 10.1136/bmj.f1035, 23520339.
107. Pinnock H, Hanley J, Lewis S, MacNee W, Pagliari C, van der Pol M, Sheikh A, McKinstry B. The impact of a telemetric chronic obstructive pulmonary disease monitoring service: randomised controlled trial with economic evaluation and nested qualitative study. Prim Care Respir J 2009, 18:233-235. 10.4104/pcrj.2009.00040, 19588056.
108. Advancing Care Coordination and Telehealth Deployment http://www.act-program.eu/.